By 8:30 most mornings, Carey Farquhar has already exercised, dropped her kids at school and taken part in at least two calls with colleagues in Kenya. A ground-breaking HIV researcher and long-time mentor, she hopes to develop a more diverse student body as well as launch more fieldwork opportunities for students in Asia. She was recently named associate chair for academic programs in the Department of Global Health.

Research Passion: Promoting HIV testing within couples in Africa

By Bruce Jancin

DURBAN, SOUTH AFRICA – Oral antiretroviral pre-exposure prophylaxis (PrEP) against HIV also reduces the risk of acquiring herpes simplex virus type 2, according to research presented at the 21st International AIDS Conference.

“Given the limited interventions for primary prevention of HSV-2, efficacy against HSV-2 provides additional benefit to oral PrEP,” observed Connie Celum, MD, professor of global health and medicine at the University of Washington, Seattle.

By Rebecca Robbins

In just the last few years, new medications have turned hepatitis C into a widely and quickly curable disease — for those who can afford it.

But the lesser-known origins of the story trace back to a 1990s laboratory invention that made it all possible. Now, two virologists who pioneered that pivotal development, and a drug researcher who created the first revolutionary drug, are being honored with one of the most prestigious awards in medical science.

By Clare McGrane

For the past year, Amazon has been cracking down on sellers and third parties offering money for positive reviews. But for one team of data scientists, negative reviews on Amazon are much more interesting than positive ones.